Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSC22 domain family member 3 | 0.619 | 0.654 | 0.43 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
RRAD and GEM like GTPase 1 | 0.531 | 0.885 | 5.3E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
C-C motif chemokine ligand 16 | 0.686 | 0.500 | 0.22 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2015 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2013 | 2019 | ||||||||
|
Potocki-Shaffer syndrome | 0.608 | 0.654 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | |||||||||
|
Myeloproliferative syndrome, transient (transient abnormal | 0.528 | 0.731 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | |||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2017 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2020 | ||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2014 | 2018 | ||||||||
|
WASP family member 1 | 0.547 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
marginal zone B and B1 cell specific protein | 0.565 | 0.769 | 3.2E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2018 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | ||||||||
|
endonuclease, poly(U) specific | 0.682 | 0.423 | 3.2E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2011 | ||||||||
|
RAR related orphan receptor A | 0.533 | 0.808 | 0.40 |
|
disease | 0.130 | None | 1.000 | 3 | 4 | 2013 | 2019 | ||||||||
|
osteoglycin | 0.631 | 0.577 | 7.4E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | ||||||||
|
adrenoceptor alpha 2B | 0.465 | 0.846 | 4.5E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2017 | ||||||||
|
WASP family member 2 | 0.585 | 0.769 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
mercaptopyruvate sulfurtransferase | 0.588 | 0.654 | 3.5E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2014 | 2018 | ||||||||
|
exosome component 6 | 0.674 | 0.462 | 0.52 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2011 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
mitogen-activated protein kinase kinase kinase 10 | 0.628 | 0.615 | 0.59 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
opioid related nociceptin receptor 1 | 0.628 | 0.462 | 0.48 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 |